Sanofi
SNY
455 hedge funds and large institutions have $11.3B invested in Sanofi in 2017 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 154 increasing their positions, 153 reducing their positions, and 61 closing their positions.
43% more funds holding in top 10
Funds holding in top 10: 7 → 10 (+3)
12% more capital invested
Capital invested by funds: $10.1B → $11.3B (+$1.18B)
1% more repeat investments, than reductions
Existing positions increased: 154 | Existing positions reduced: 153
0.1% less ownership
Funds ownership: 19.43% → 19.33% (-0.1%)
9% less call options, than puts
Call options by funds: $49.9M | Put options by funds: $55M
4% less funds holding
Funds holding: 476 → 455 (-21)
23% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 61
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$64.3M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$47.7M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$37.8M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$34.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$24.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Harris Associates
Chicago,
Illinois
|
-$131M |
| 2 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$41.3M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$24.3M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$23M |
| 5 |
Dodge & Cox
San Francisco,
California
|
-$22.5M |
SNY Hedge Fund Activity: Q1 2017 in Review
455 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q1 2017, worth a combined $11.3B — up 12% from $10.1B a quarter earlier.
Sellers outnumbered buyers: 61 funds closed out of SNY and 47 opened new positions — a net loss of 14 holders — while 153 trimmed existing stakes and 154 added.
The largest buyer was BlackRock, adding an estimated $64.3M. The largest seller was Harris Associates, exiting entirely with an estimated $131M sold.
- 455 institutional investors held Sanofi (SNY) as of Q1 2017, down from 476 in Q4 2016.
- Funds reported $11.3B of Sanofi stock for Q1 2017, up 12% quarter-over-quarter.
- 47 funds opened new Sanofi positions in Q1 2017 and 61 closed out, a net change of -14 holders.
- The largest Sanofi buyer in Q1 2017 was BlackRock, an estimated $64.3M added.
- The largest Sanofi seller in Q1 2017 was Harris Associates, an estimated $131M sold.
Based on aggregated 13F filings for Q1 2017.